Carvedilol Tablet, Film Coated
Product Images NDC 71610-062

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 71610-062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 3.125 mg (71610 0062 53)

Bottle Label 3.125 mg (71610 0062 53)
The text is a mixture of English and non-English characters and appears to be a product name for a medication, specifically 3.125mg Carvedilol tablets packaged in a bottle containing 60 tablets.*
FDA Label Image

Bottle Label 6.25 mg (71610 0063 53)

Bottle Label 6.25 mg (71610 0063 53)
This is a medication called Carvedilol available in a 6.25mg strength with 60 tablets per container. The NOC (Notice of Compliance) number for this medication is 7161008353.*
FDA Label Image

Bottle Label 12.5 mg (71610 0066 60)

Bottle Label 12.5 mg (71610 0066 60)
This is a medication called Carvedilol available in tablet form. The dosage may either be 12.5mg or 125mg depending on the prescription, with the latter requiring a prescription (S0). The second line may be a reference number or code. The quantity for the 12.5mg dosage is 90 tablets.*
FDA Label Image

Bottle Label 25 mg (71610 0067 60)

Bottle Label 25 mg (71610 0067 60)
Carvedilol is a medication commonly used to treat high blood pressure and heart failure. The package appears to contain 90 tablets, each containing 25mg of the active ingredient. The product is labeled with a NOC number of 7161006750.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1 (Figure 1)

FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
This appears to be a tabular representation of several demographic and medical variables, likely from a clinical study or trial. The variables include age, race, diabetes status, heart rate, blood pressure, and use of spironolactone medication. However, it is not possible to discern any further information or context without additional information or further data.*
FDA Label Image

Figure 3 (Figure 3)

FDA Label Image

Figure 4 (Figure 4)

FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.